Q&A: When might the coronavirus vaccines get full approval?

Additionally, the manufacturing for a full approval has to be much more well-described and detailed than it is for an emergency use authorization. Plus, we have to do additional inspections of facilities and I can say that for Pfizer, there are lots of facilities involved in different countries, so there’s a lot of things to tie up in order to put a ribbon around this package. Because, at the end of the day, when we put this forward as a licensed product, we don’t want someone to say, “Well, they didn’t come and inspect this time and, by the way, there is something wrong here.”

View original article here Source

Related Posts